Pasireotide and its pharmaceutically acceptable derivatives (SIGNIFOR)
- 专利权人:
- NOVARTIS AG
- 发明人:
- 申请号：
- LU92024
- 公开号：
- LU92024I2
- 申请日:
- 2012.06.20
- 申请国别(地区):
- LU
- 年份:
- 2012
- 代理人:
- 摘要：
- The invention provides cyclo[{4-(NH2&mdash；C2H4&mdash；NH&mdash；CO&mdash；O&mdash；)Pro}-Phg-DTrp-Lys-Tyr(4-Benzyl)-Phe], optionally in protected form, or a pharmaceutically acceptable salt or complex thereof, which has interesting pharmaceutical properties.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Somatostatin analogues
- NOVEL PROCESS FOR THE PREPARATION OF PASIREOTIDE
- Szomatosztatin analógok, azokat tartalmazó gyógyszerkészítmények és alkalmazásuk
- MICROPARTICLES COMPRISING CYCLO [{4-(NH2-C2H4-NH-CO-O)PRO}-PHG-DTRP-LYS-TYR(4-BZL)-PHE] IN FREE FORM, SALT FORM OR PROTECTED FORM EMBEDED IN A POLYMER MATRIX, PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND USE THEREOF IN THE PREPARATION OF MEDICAMENTS
- Melanocortin receptor-specific peptides
